Drug Evaluation and Research News

Carcinogen in Zantac and Its Generics Triggers Probes by FDA, EU

Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that has sparked a worldwide recall of blood-pressure pills. Drug-safety officials in the …